Interpace Biosciences, Inc. (IDXG)

Interpace Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 27, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12	5	4	31	13	19
Market Cap Growth	94.89%	5.76%	-85.77%	145.72%	-33.55%	-16.51%
Enterprise Value	63	60	58	87	53	45
Last Close Price	2.65	1.08	1.04	7.47	3.14	5.00
PE Ratio	2.39	5.85	-	-	-	-
PS Ratio	0.26	0.12	0.14	0.94	0.39	0.79
PB Ratio	-0.71	-0.31	-0.27	7.57	0.73	0.88
P/FCF Ratio	3.14	1.41	-	-	-	-
P/OCF Ratio	1.72	1.24	-	-	-	-
EV/Sales Ratio	1.41	1.49	1.82	2.62	1.63	1.86
EV/EBITDA Ratio	8.60	15.57	-	-	-	-
EV/EBIT Ratio	9.95	21.25	-	-	-	-
EV/FCF Ratio	17.04	18.00	-	-	-	-
Debt / Equity Ratio	-0.64	-0.74	-0.97	2.60	0.27	0.33
Debt / EBITDA Ratio	0.98	2.41	-	34.59	-	-
Debt / FCF Ratio	1.93	3.37	-	-	-	-
Asset Turnover	3.17	2.77	1.17	0.79	0.67	0.48
Inventory Turnover	15.35	13.31	13.28	9.95	11.18	-
Quick Ratio	0.50	0.49	0.69	0.47	0.59	0.73
Current Ratio	0.59	0.59	0.85	0.78	0.77	0.95
Return on Equity (ROE)	-	-	-	-65.25%	-133.86%	-97.57%
Return on Assets (ROA)	28.09%	12.12%	-8.82%	-8.57%	-30.83%	-29.94%
Return on Capital (ROIC)	-	-	-33.34%	-19.45%	-58.78%	-48.49%
Earnings Yield	40.24%	17.09%	-494.86%	-47.92%	-208.43%	-140.01%
FCF Yield	31.84%	70.72%	-180.61%	-29.10%	-122.56%	-99.95%
Buyback Yield / Dilution	-2.28%	-2.97%	-2.49%	-2.63%	-7.55%	-33.03%
Total Shareholder Return	-2.28%	-2.97%	-2.49%	-2.63%	-7.55%	-33.03%

Source: S&P Capital IQ. Standard template. Financial Sources.